Estimated 2.6 million Americans prescribed opioids also on various other sedatives

opioids
Credit: CC0 Public Domain

As many as 2.6 million Americans—equivalent to 1 percent of all US adults —prescribed opioids are also taking various other sedatives, including benzodiazepines plus another type of sedative drug, estimates research published online in the journal Regional Anesthesia & Pain Medicine.

This type of polypharmacy could be dangerous, warn the researchers, who call for further research into the safety of this approach.

The known side effects of concurrent use of opioids and sedatives, such as , may be even stronger in those prescribed other types of anti-anxiety drugs, such as trazodone, an antidepressant often used to treat like sleep apnoea and insomnia, say the researchers.

To explore this further, the study authors wanted to gauge the extent of dual anti-anxiety/ therapy among US adult opioid users.

They drew on nationally representative data from the Medical Expenditure Panel Survey (MEPS), which includes US comprehensive data on healthcare expenditure, , and for American citizens living independently.

After aggregating the 4 most recent years of MEPS data (2016–19), the researchers identified 28.4 million prescription opioid users aged 18 and above, of whom nearly 1 in 10 (10,700; just over 9%) had also been prescribed benzodiazepines plus other types of sedatives in the same calendar year.

Among this group, the annual average number of prescriptions filled for opioids, benzodiazepines, and other types of sedatives was nearly 25 per person.

Dual sedative/anxiolytic therapy was most common among middle-aged adults, women, and those of non-Hispanic white ethnicity.

The highest rates of dual therapy were observed among opioid users with severe pain, anxiety, depression, stress-related and sleep disorders.

When stratified by the number of opioid prescriptions, those in receipt of five or more every year had a dual prescription rate of nearly 18.5%.

Based on these figures, the researchers estimate that 2.6 million American adults, equivalent to 1% of the US adult population, are prescribed an , benzodiazepine, plus another type of sedative.

This is an observational study, and as such, can’t establish cause. And the researchers point out that MEPS doesn’t provide details on the sequencing of prescriptions over a year. The list of benzodiazepines included in their list may not have been comprehensive either, they acknowledge.

But they emphasise: “No current guidelines exist regarding the safety of this prescribing practice, especially in subpopulations that may be particularly susceptible to sedation,” adding that “there are complex interactions among , pain, and sleep disorders.”

They conclude: “We find that a surprisingly high number of Americans prescribed opioids are also undergoing treatment that includes a dual combination of anxiolytic and sedative medications.

“Given the potential dangers of this polypharmacy approach, future studies are warranted to determine the level of safety, especially among vulnerable population.”



More information:
Anxiolytic and sedative polypharmacy among US opioid users: a cross-sectional study, Regional Anesthesia & Pain Medicine, DOI: 10.1136/rapm-2021-103278

Citation:
Estimated 2.6 million Americans prescribed opioids also on various other sedatives (2022, February 22)
retrieved 10 March 2022
from https://medicalxpress.com/news/2022-02-million-americans-opioids-sedatives.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Is Long COVID Less Likely With Omicron Strains? thumbnail

Is Long COVID Less Likely With Omicron Strains?

Please enable cookies. Error 1005 Ray ID: 791548dd79316eb8 • 2023-01-29 22:08:07 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 791548dd79316eb8 • Your IP: 217.21.81.33 •
Read More
What Happens When You Stop Drinking Alcohol? thumbnail

What Happens When You Stop Drinking Alcohol?

Drinking also accelerates other signs of facial aging. In a 2019 study published in the Journal of Clinical and Aesthetic Dermatology, which involved women of multiple races and nationalities, researchers found that women who had roughly one drink a day reported eye puffiness and loss of volume in their faces. Women who had around eight…
Read More
LGBTQ activist and ex-UBS banker Scott Miller becomes US ambassador to Switzerland thumbnail

LGBTQ activist and ex-UBS banker Scott Miller becomes US ambassador to Switzerland

Der Senat hat Präsident Bidens Kandidat für den Posten des amerikanischen Botschafters in der Schweiz und Liechtenstein bestätigt. Wann Scott Miller als US-Botschafter nach Bern kommt, ist noch unklar. Matthew Staver / PD mbe./(Reuters) Der neue amerikanische Botschafter in Bern heisst Scott Miller. Der 41-jährige Philanthrop und LGBTQ-Aktivist aus Denver, Colorado, wurde im August von…
Read More
Check Mac and Cheese Recipe, Easy and Filling! thumbnail

Check Mac and Cheese Recipe, Easy and Filling!

MAMA Lita kembali dengan konten masak-masak di YouTube channel miliknya. Ada yang berbeda, kali ini Mama Lita ditemani oleh kedua anak laki-lakinya untuk memasak mac & cheese. Mac and cheese atau makaroni dan keju merupakan menu populer asal Amerika yang sering disajikan sebagai makanan rumahan yang lezat. Pasta al dente dipadukan dengan lelehan keju yang…
Read More
Stimulant Reduces Apathy in Alzheimer's Disease thumbnail

Stimulant Reduces Apathy in Alzheimer’s Disease

Treatment with methylphenidate (Ritalin), a stimulant approved for attention deficit-hyperactivity disorders (ADHD) and narcolepsy, led to a small to medium reduction in apathy in people with Alzheimer's disease, the phase III ADMET 2 trial showed. At 6 months, methylphenidate 10 mg twice daily led to a larger decrease on the 12-point Neuropsychiatric Inventory (NPI) apathy…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share